EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Computational biology and artificial intelligence in mRNA vaccine design for cancer immunotherapy

Saber Imani, Xiaoyan Li, Keyi Chen, Mazaher Maghsoudloo, Parham Jabbarzadeh Kaboli, Mehrdad Hashemi, Saloomeh Khoushab, Xiaoping Li

Frontiers in Cellular and Infection Microbiology · 20.01.2025 · 14

DOI: 10.3389/fcimb.2024.1501010 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 20.01.2025. Verfasst von Saber Imani und 7 weiteren Autor:innen. Beteiligte Einrichtung: Shulan International Medical College, Zhejiang Shuren University, Hangzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Artificial Intelligence, Computational Biology, Immunotherapy, Neoplasms. Die Arbeit wurde bisher 77-mal zitiert (Crossref) und nennt 188 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Messenger RNA (mRNA) vaccines offer an adaptable and scalable platform for cancer immunotherapy, requiring optimal design to elicit a robust and targeted immune response. Recent advancements in bioinformatics and artificial intelligence (AI) have significantly enhanced the design, prediction, and optimization of mRNA vaccines. This paper reviews technologies that streamline mRNA vaccine development, from genomic sequencing to lipid nanoparticle (LNP) formulation. We discuss how accurate predictions of neoantigen structures guide the design of mRNA sequences that effectively target immune and cancer cells. Furthermore, we examine AI-driven approaches that optimize mRNA-LNP formulations, enhancing delivery and stability. These technological innovations not only improve vaccine design but also enhance pharmacokinetics and pharmacodynamics, offering promising avenues for personalized cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Artificial IntelligenceComputational BiologyImmunotherapyNeoplasmsCancer VaccinesmRNA VaccinesRNA, MessengerVaccine DevelopmentHumansAntigens, NeoplasmVaccines, SyntheticNanoparticles

Stichwörter der Autor:innen

artificial intelligencebioinformaticslipid nanoparticlesneo-antigen mRNA vaccinestargeted immunotherapy

Substanzen

Cancer VaccinesmRNA VaccinesRNA, MessengerAntigens, NeoplasmVaccines, Synthetic

Autor:innen und Institutionen

  • Shulan International Medical College, Zhejiang Shuren University, Hangzhou, Zhejiang, China.
  • Key Laboratory of Artificial Organs and Computational Medicine in Zhejiang Province, Shulan International Medical College, Zhejiang Shuren University, Hangzhou, Zhejiang, China.
  • Key Laboratory of Epigenetics and Oncology, the Research Center for Preclinical Medicine, Southwest Medical University, Luzhou, Sichuan, China.
  • Department of Biochemistry, Faculty of Medicine, Medical University of Warsaw, Warsaw, Poland.
  • Department of Genetics, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
  • Farhikhtegan Medical Convergence sciences Research Center, Farhikhtegan Hospital Tehran Medical sciences, Islamic Azad University, Tehran, Iran.

Zitieren

APA

Imani, S., Li, X., Chen, K., Maghsoudloo, M., Jabbarzadeh Kaboli, P., Hashemi, M., Khoushab, S., & Li, X. (2025). Computational biology and artificial intelligence in mRNA vaccine design for cancer immunotherapy. Frontiers in Cellular and Infection Microbiology, 14. https://doi.org/10.3389/fcimb.2024.1501010

Vancouver

Imani S, Li X, Chen K, Maghsoudloo M, Jabbarzadeh Kaboli P, Hashemi M, et al. Computational biology and artificial intelligence in mRNA vaccine design for cancer immunotherapy. Frontiers in Cellular and Infection Microbiology. 2025;14. doi:10.3389/fcimb.2024.1501010

BibTeX
@article{Imani2025,
  author = {Imani, Saber and Li, Xiaoyan and Chen, Keyi and Maghsoudloo, Mazaher and Jabbarzadeh Kaboli, Parham and Hashemi, Mehrdad and Khoushab, Saloomeh and Li, Xiaoping},
  title = {Computational biology and artificial intelligence in mRNA vaccine design for cancer immunotherapy},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2025},
  volume = {14},
  doi = {10.3389/fcimb.2024.1501010}
}
Kostenlos starten →